1612P Immunogenicity of two doses of inactive COVID-19 vaccine and third booster dose mRNA vaccine in patients with cancer receiving active systemic therapy

por Guven, D.C.C., Gulbahce Incesu, F.G., Yildirim, H.C., Erul, E., Chalabiyev, E., Aktas, B.Y., Yuce, D., Arik, Z., Kilickap, S., Aksoy, S., Erman, M., Hayran, K.M., Unal, S., Alp, A., Dizdar, O.
Publicado 2022